Now, I have read extensively about the War on Drugs, the history of drugs, the science, the legal policy–and even the government weed grown at the University of Mississippi!–but this is the first I have read about a patent on medical marijuana as a neuroprotectant, which is held by the United States Department of Health and Human Services. And yet, this same federal government still classifies this plant as a Schedule I drug. Ganjay Supta–duh, I mean–medical reporter Sanjay Gupta, who has recently converted into an advocate for medical marijuana, reports this “hypocrisy.”
VIA RAW Story
CNN contributor Dr. Sanjay Gupta followed up on his reversal of course regarding medical marijuana in an interview with Anderson Cooper on Tuesday by slamming federal policy regarding medical marijuana.
“The U.S. holds a patent [on marijuana] on one hand, and on the other hand, same government says it has no medical applications,” Gupta told Cooper. “Journalists are trained to hate hypocrisy. This is hypocrisy. I’ve never seen it quite like this.”
The Department of Health and Human Services, Gupta explained, holds a patent on medical marijuana as “a protectant for the brain, giving voice to an argument made by medical marijuana proponents. The pro-marijuana site Weedist reported in May 2013 that the patent states that, “cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”